Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 12 EP applications Barbara Kunic Tesovic has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after July 03, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12150892

Preparation of Optically Pure ss-Amino Acid Type Active Pharmaceutical Ingredients and Intermediates thereof

IPC classification:
C07C 67/31, C07C 303/40, C07C 269/06, C07C 227/34, C07F 5/02, C07C 239/20, C07C 231/06, C07C 211/27
Applicant:
LEK Pharmaceuticals dd
Agent:
Barbara Kunic Tesovic, LEK Pharmaceuticals dd
Status:
APPLICATION REFUSED
EP12156137

Synthesis of 2-(3,4-difluorophenyl)cyclopropanecarboxylic acid

IPC classification:
C07D 487/04, C07C 211/40, C07C 255/46, C07C 255/30, C07C 255/16, C07C 253/30, C07C 253/14, C07C 69/74, C07C 69/732, C07C 67/31, C07C 67/08, C07C 51/41, C07C 51/083, C07C 51/08, C07C 45/68, C07C 67/327
Applicant:
LEK Pharmaceuticals dd
Agent:
Barbara Kunic Tesovic, LEK Pharmaceuticals dd
Status:
APPLICATION REFUSED
EP12162491

Synthetic route for the preparation of substituted 2-phenyl-1,2,3,4-tetrahydronaphthalene-1-ols

IPC classification:
C07C 43/23, C07C 41/26, C07D 295/088
Applicant:
LEK Pharmaceuticals dd
Agent:
Barbara Kunic Tesovic, LEK Pharmaceuticals dd
Status:
APPLICATION REFUSED
EP12163500

ss-boration of alkene and alkyne intermediates

IPC classification:
C07F 5/02
Applicant:
LEK Pharmaceuticals dd
Agent:
Barbara Kunic Tesovic, LEK Pharmaceuticals dd
Status:
APPLICATION REFUSED
EP12162507

Synthesis of 2-(3,4-difluorophenyl)cyclopropanamine derivatives and salts

IPC classification:
C07C 209/56
Applicant:
LEK Pharmaceuticals dd
Agent:
Barbara Kunic Tesovic, LEK Pharmaceuticals dd
Status:
APPLICATION REFUSED
EP12172389

Genome sequence based targeted cloning of DNA fragments

IPC classification:
C12N 15/70
Applicant:
LEK Pharmaceuticals dd
Agent:
Barbara Kunic Tesovic, LEK Pharmaceuticals dd
Status:
APPLICATION REFUSED
EP12172012

New synthetic route for the preparation of ss aminobutyryl substituted 5,6,7,8-tetrahydro[1,4]diazolo[4,3-alpha]pyrazin-7-yl compounds

IPC classification:
C07D 205/08, A61P 3/10, A61K 31/4985, C07D 487/04
Applicant:
LEK Pharmaceuticals dd
Agent:
Barbara Kunic Tesovic, LEK Pharmaceuticals dd
Status:
APPLICATION REFUSED
EP13163019

Purification of Posaconazole Intermediates

IPC classification:
C07D 405/12, C07D 405/06
Applicant:
Sandoz AG
Agent:
Barbara Kunic Tesovic, LEK Pharmaceuticals dd
Status:
APPLICATION REFUSED
EP12002520

ss-boration of alkene and alkyne intermediates

IPC classification:
C07F 5/04
Applicant:
LEK Pharmaceuticals dd
Agent:
Barbara Kunic Tesovic, LEK Pharmaceuticals dd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13173184

Spherical ticagrelor particles

IPC classification:
A61K 31/519, A61K 9/20, C07D 487/04
Applicant:
LEK Pharmaceuticals dd
Agent:
Barbara Kunic Tesovic, LEK Pharmaceuticals dd
Status:
APPLICATION REFUSED
EP13150217

Crystalline form of apixaban

IPC classification:
A61K 31/437, C07D 471/04, A61P 7/02
Applicant:
Sandoz AG
Agent:
Barbara Kunic Tesovic, LEK Pharmaceuticals dd
Status:
APPLICATION REFUSED
EP12169182

Synthesis of Aminocyclopentanetriol Derivatives

IPC classification:
C07D 317/26
Applicant:
LEK Pharmaceuticals dd
Agent:
Barbara Kunic Tesovic, LEK Pharmaceuticals dd
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature